The Tensilon test is a method to help diagnose
Myasthenia gravis - Tensilon test; Edrophonium test
How the Test is Performed
A medicine called Tensilon (also called edrophonium) is given during this test. The health care provider gives the medicine through one of your veins (intravenously, through an IV). You may also be given a medicine called atropine before receiving Tensilon to reduce chances of side effects. Your heart rate may be monitored to make sure the medicine doesn't slow your heart down.
You will be observed for any improvement in strength from the medicine. Muscles that are weak will be tested before and right after the medicine is given. Any weak muscles are monitored, although the muscles of the eyes or face are most commonly tested.
The test may be repeated and you may have other Tensilon tests to help tell the difference between myasthenia gravis and other conditions.
How to Prepare for the Test
No special preparation is usually necessary. Follow your provider's instructions about how to prepare.
How the Test will Feel
You will feel a sharp prick as the IV needle is inserted. The medicine may cause a feeling of a churning of the stomach or a slight feeling of decreased heart rate, especially if atropine is not given first.
Why the Test is Performed
The test helps:
- Diagnose myasthenia gravis
- Tell the difference between myasthenia gravis and other similar brain and nervous system conditions
- Monitor treatment with oral anticholinesterase drugs
The test may also be done for conditions such as
What Abnormal Results Mean
In many people with myasthenia gravis, the muscle weakness will improve right after receiving Tensilon. The improvement lasts only a few minutes. For some types of myasthenia, Tensilon may make the weakness worse.
When the disease gets worse enough to need treatment (myasthenic crisis), there is a brief improvement in muscle strength.
When there is an overdose of anticholinesterase (cholinergic crisis), Tensilon will make the person even weaker.
The medicine used during the test may cause side effects, including low heart rate, fainting, nausea, or breathing failure. This is why the test is done by a provider in a medical setting.
Guptill JT, Sanders DB. Disorders of neuromuscular transmission. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 108.
Naji A, Owens ML. Edrophonium. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
Zhou J, Nozari A, Bateman B, Allen PD, Pessah IN. Neuromuscular disorders including malignant hyperthermia and other genetic disorders. In: Gropper MA, ed. Miller's Anesthesia. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 35.
Review Date: 01/23/2023
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright ©2019 A.D.A.M., Inc., as modified by University of California San Francisco. Any duplication or distribution of the information contained herein is strictly prohibited.
Information developed by A.D.A.M., Inc. regarding tests and test results may not directly correspond with information provided by UCSF Health. Please discuss with your doctor any questions or concerns you may have.